
Results
2
Companies which are more than 50% undervalued based on analyst price target.
2 companies
Pharming Group
Market Cap: €624.8m
A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.
PHARM
€0.88
7D
-19.7%
1Y
-16.1%
Vivoryon Therapeutics
Market Cap: €35.5m
Operates as a clinical stage biopharmaceutical company that focuses on research, development, and commercialize small molecule-based medicines.
VVY
€1.20
7D
4.3%
1Y
-17.2%